International ophthalmology · 2025
Early success and safety of three minimally invasive glaucoma surgery techniques combined with cataract surgery in glaucoma patients.
СтатьяНаблюдательное исследованиеНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Nassri Humam, Prinz Julia, Fuest Matthias, Walter Peter, Plange Niklas, Kuerten David
Аннотация
PURPOSE: To evaluate the efficacy and safety of three minimally invasive glaucoma surgery (MIGS) techniques, OMNI® Surgical System (OMNI), VISCO360® Surgical System (VISCO) and goniotomy using the Kahook Dual Blade (KDB) in combination with phacoemulsification in glaucoma patients.
METHODS: This prospective observational study over 6 months included 93 glaucoma patients who underwent one of the three MIGS combined with cataract surgery. Indications for surgery were insufficient intraocular pressure (IOP) control under topical medication or reducing the medication burden. Complete success was defined as reaching IOP < 21 mmHg without topical medication while qualified success was considered reaching IOP < 21 mmHg with topical medication.
RESULTS: The preoperative IOP was lowered significantly after 6 months for all 3 MIGS procedures and no significant differences in-between the 3 devices were recorded. Topical glaucoma medication was also reduced in all three groups, without a significant difference. Complete surgical success was the highest in KDB patients after 6 months at 74.2%, followed by 58.1% in VISCO and 48.4% in OMNI patients.
CONCLUSION: OMNI, VISCO or KDB in combination with phacoemulsification are safe and effective treatment options for glaucoma patients. The KDB and VISCO groups achieved higher success rates than OMNI, however, no significant differences in medication burden as well as IOP were recorded in-between the 3 devices.
METHODS: This prospective observational study over 6 months included 93 glaucoma patients who underwent one of the three MIGS combined with cataract surgery. Indications for surgery were insufficient intraocular pressure (IOP) control under topical medication or reducing the medication burden. Complete success was defined as reaching IOP < 21 mmHg without topical medication while qualified success was considered reaching IOP < 21 mmHg with topical medication.
RESULTS: The preoperative IOP was lowered significantly after 6 months for all 3 MIGS procedures and no significant differences in-between the 3 devices were recorded. Topical glaucoma medication was also reduced in all three groups, without a significant difference. Complete surgical success was the highest in KDB patients after 6 months at 74.2%, followed by 58.1% in VISCO and 48.4% in OMNI patients.
CONCLUSION: OMNI, VISCO or KDB in combination with phacoemulsification are safe and effective treatment options for glaucoma patients. The KDB and VISCO groups achieved higher success rates than OMNI, however, no significant differences in medication burden as well as IOP were recorded in-between the 3 devices.